New asthma inhaler begins human safety testing
NCT ID NCT06916273
Summary
This was an early safety study for a new inhaled steroid medication called PA9159, intended for future use in asthma. The study tested single and repeated doses in 40 healthy Chinese adults to see how their bodies handled the drug and to check for any side effects. The main goal was to find the highest dose that could be given safely.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHIAL ASTHMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, 330006, China
Conditions
Explore the condition pages connected to this study.